KU-60019

For research use only. Not for use in humans.

Catalog No.S1570

58 publications

KU-60019 Chemical Structure

Molecular Weight(MW): 547.67

KU-60019 is an improved analogue of KU-55933, with IC50 of 6.3 nM for ATM in cell-free assays, 270- and 1600-fold more selective for ATM than DNA-PK and ATR,and is a highly effective radiosensitizer.

Size Price Stock Quantity  
10mM (1mL in DMSO) USD 195 In stock
USD 150 In stock
Bulk Discount
Bulk Inquiry

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Selleck's KU-60019 has been cited by 58 publications

Purity & Quality Control

Choose Selective ATM/ATR Inhibitors

Biological Activity

Description KU-60019 is an improved analogue of KU-55933, with IC50 of 6.3 nM for ATM in cell-free assays, 270- and 1600-fold more selective for ATM than DNA-PK and ATR,and is a highly effective radiosensitizer.
Features Improved analog of KU-55933, and is more effective at blocking ATM-mediated DDR events.
Targets
ATM [1]
(Cell-free assay)
6.3 nM
In vitro

Compared to KU-55933, KU-60019 is an improved more water-soluble inhibitor of the ATM kinase, while displaying similar target selectivity. KU-60019 has little activity against DNA-PKcs and ATR with IC50 values of 1.7 μM and >10 μM, respectively, as well as 229 other protein kinases such as PI3K, mTOR and mTOR/FKBP12. KU-60019 displays 3- to 10-fold more potency than KU-55933 at blocking radiation-induced phosphorylation of key ATM protein targets such as p53, γ-H2AX, and CHK2, in human glioma U87 and U1242 cells, as 1 μM of KU-60019 significantly induces >70% decrease of p53 (S15) phosphorylation to which extent ~10 μM of KU-55933 is required to achieve. KU-60019 effectively radiosensitizes human glioma cells with dose-enhancement ratio of 1.7 and 4.4 at 1 μM and 10 μM, respectively, and also radiosensitizes the normal fibroblasts but not the A-T fibroblasts. KU-60019 treatment (3 μM) blocks basal and insulin-induced AKT S473 phosphorylation by 70% and ~50%, respectively, and completely reduces radiation-induced AKT phosphorylation below the level of control. The effect of KU-60019 on AKT S473 phosphorylation can be seen in glioma cell lines and normal fibroblasts but not in A-T (h-TERT) cells, and can be significantly blocked by phosphatase inhibitor okadaic acid, suggesting a critical role of ATM kinase in regulating AKT phosphorylation via unknown phosphatase. Consistent with the inhibition of prosurvival AKT signaling, KU-60019 at 3 μM significantly inhibits migration and invasion of human glioma U87 cells by >70% and ~60%, respectively, as well as U1242 cells by >50% and ~60% respectively. [1]
Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
BAECs MXvGeY5kfGmxbjDBd5NigQ>? MXexNOKh|ryP NEHPWIoyyqCqwrC= NWjzdnFCTE2VTx?= M33jc4Fjd2yrc3jld{B1cGVicHjvd5Bpd3K7bHH0bY9vKG:oIFHUUU1U\XJzOUix MYKyOVQ6QDV2Mh?=
BAECs M1K1UmZ2dmO2aX;uJGF{e2G7 MmX4NVDDqM7:TR?= M2GyRlHDqGkEoB?= NYHEUJNKTE2VTx?= M4X6OIlvcGmkaYTzJJRp\SCrbnPy[YF{\SCrbjDOU3Mh[WO2aY\peJk> MnHjNlU1QTh3NEK=
U1242 MVvLbY5ie2ViQYPzZZk> MX[zJO69VcLi NFv5S2QxNjViaB?= MVLEUXNQ Mk\uxsBqdmirYnn0d{B1cGViQWTNJItqdmG|ZR?= M4\LfVI{PjJyNEC5
U87 NHnLfYRMcW6jc3WgRZN{[Xl? M{XBfFMh|ryPwrC= NVrXSmNqOC53IHi= MUjEUXNQ M1rPU:KhcW6qaXLpeJMhfGinIFHUUUBscW6jc3W= NGC4[5UzOzZ{MESwPS=>
U1242 M33tXmFxd3C2b4Ppd{BCe3OjeR?= Mn\xN{DPxE4EoB?= NILGclcyyqCqwrC= Ml;mSG1UVw>? NVzqVlY6emGmaX;z[Y5{cXSrenXzJIh2dWGwIHfsbY9u[SClZXzsdy=> NEHMT4QzOzZ{MESwPS=>
U87 NGjuVnhCeG:ydH;zbZMhSXO|YYm= M1jETlMh|ryPwrC= MVuxxsBpyqB? Mn[wSG1UVw>? M2LzZZJi\Gmxc3Xud4l1cXqnczDoeY1idiCpbHnvcYEh[2WubIO= MkG0NlM3OjB2MEm=
U1242  MYPLbY5ie2ViQYPzZZk> MoTqNE4xOS1|IN88UeKh M3rKdVEhcA>? M4nLeWROW09? NW\IfIoy[myxY3vzJGFVVSCtaX7hd4Uh[WO2aY\peJkh[XRibH;3JINwdmOnboTyZZRqd26| NWnETXYzOjJ|N{C0PFU>

... Click to View More Cell Line Experimental Data
Assay
Methods Test Index PMID
Western blot
p-ATM / ATM / p-AKT / AKT / PKM2 ; 

PubMed: 30799198     


CAFs (Cancer-associated fibroblasts) were cultured in normoxia or hypoxia for 8 h and treated with or without KU60019 (5 μM), protein levels of p-ATM, ATM, p-AKT, AKT and PKM2 were determined by Western blotting.

30799198
Immunofluorescence
GLUT1; 

PubMed: 30799198     


CAFs (Cancer-associated fibroblasts) were cultured in normoxia or hypoxia for 8 h and treated with or without KU60019 (5 μM), the membrane GLUT1 was shown by immunofluorescence staining. Scale bar, 50 μm. 

30799198
In vivo In orthotopic glioma U1242/luc-GFP xenograft models, the combination of KU-60019 and radiation significantly increases survival of mice than KU-60019 alone, radiation alone, or no treatment. In addition, p53-mutant gliomas is much more sensitive to KU-60019 radiosensitization than wild-type glioma. [2]

Protocol

Cell Research:[1]
- Collapse
  • Cell lines: U87 and U1242
  • Concentrations: Dissolved in water, final concentrations ~3 μM
  • Incubation Time: 1, 3, and 5 days
  • Method: Cells are exposed to KU-60019 for 1, 3, and 5 days. Cell growth is determined by AlamarBlue. AlamarBlue is added to the medium to the recommended final concentration. Plates are incubated for 1 hour at 37 °C, fluorescence is determined on a Fluoro-Count plate reader (excitation 530 nm, emission 590 nm), and values are taken as a measure of cell growth. Cell survival is determined by trypan blue/fluorescence activated cell sorting (FACS) assay.
    (Only for Reference)
Animal Research:[2]
- Collapse
  • Animal Models: Athymic female mice harboring orthotopic glioma U1242/luc-GFP tumors or human glioma U1242/luc-GFP tumors
  • Formulation: PBS
  • Dosages: KU-60019 (10 μM) is delivered at a rate of 0.5 μL/h by osmotic pump; KU-60019 (250 μM) in 12.5 μL is infused by CED.
  • Administration: Administered intratumorally by convection-enhanced delivery or osmotic pump
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 18 mg/mL warmed (32.86 mM)
Water Insoluble
Ethanol Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 547.67
Formula

C30H33N3O5S
CAS No. 925701-49-1
Storage powder
in solvent
Synonyms N/A
Smiles CC1CN(CC(C)O1)CC(=O)NC2=CC3=C(SC4=C(C3)C=CC=C4C5=CC(=O)C=C(O5)N6CCOCC6)C=C2

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    what vehicle do you recommend for in vivo use of this compound?

  • Answer:

    The formula for i.p. injections: 5% stock solution (100mg/ml) +30% PEG 300+ddH2O could reach a final concentration of 5mg/ml.

selleck catalog

ATM/ATR Signaling Pathway Map

ATM/ATR Inhibitors with Unique Features

Related ATM/ATR Products

  • AZD6738(Ceralasertib) New

    AZD6738 is an orally active, and selective ATR kinase inhibitor with IC50 of 1 nM. Phase 1/2.

  • CHIR-99021 (CT99021) New

    CHIR-99021 (CT99021) is a GSK-3α and GSK-3β inhibitor with IC50 of 10 nM and 6.7 nM, respectively. CHIR99201 does not exhibit cross-reactivity against cyclin-dependent kinases (CDKs) and shows a 350-fold selectivity toward GSK-3β compared to CDKs.

  • Dorsomorphin (Compound C) New

    Dorsomorphin is a potent, reversible, selective AMPK inhibitor with Ki of 109 nM in cell-free assays, exhibiting no significant inhibition of several structurally related kinases including ZAPK, SYK, PKCθ, PKA, and JAK3. Also inhibits type I BMP receptor activity.

  • KU-55933 (ATM Kinase Inhibitor)

    KU-55933 (ATM Kinase Inhibitor) is a potent and specific ATM inhibitor with IC50/Ki of 12.9 nM/2.2 nM in cell-free assays, and is highly selective for ATM as compared to DNA-PK, PI3K/PI4K, ATR and mTOR.

  • VE-821

    VE-821 is a potent and selective ATP competitive inhibitor of ATR with Ki/IC50 of 13 nM/26 nM in cell-free assays, shows inhibition of H2AX phosphorylation, minimal activity against PIKKs ATM, DNA-PK, mTOR and PI3Kγ.

  • Berzosertib (VE-822)

    VE-822 is an ATR inhibitor with IC50 of 19 nM in HT29 cells.

    Features:VE-822 is a highly selective and potent derivative of the ATR inhibitor VE-821.

  • Chloroquine diphosphate

    Chloroquine diphosphate is a 4-aminoquinoline anti-malarial and anti-rheumatoid agent, also acting as an ATM activator.

  • AZ20

    AZ20 is a novel potent and selective inhibitor of ATR kinase with IC50 of 5 nM in a cell-free assay, 8-fold selectivity over mTOR.

    Features:AZ20 is the first reported inhibitor of ATR protein kinase demonstrating tumor growth inhibition in vivo.

  • CP-466722

    CP-466722 is a potent and reversible ATM inhibitor, does not affect ATR and inhibits PI3K or PIKK family members in cells.

  • ETP-46464

    ETP-46464 is a potent and selective inhibitor of ATR with IC50 of 25 nM.

    Features:Selective ATR inhibitor and particularly toxic to p53-deficient cancer cells. Often used as a pharmacologic probe due to its ideal pharmacological properties.

Tags: buy KU-60019 | KU-60019 supplier | purchase KU-60019 | KU-60019 cost | KU-60019 manufacturer | order KU-60019 | KU-60019 distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID